[Expressing foreign genes by Newcastle disease virus for cancer therapy]
/in International Publications, Newcastle Disease VirusMatched-pair analysis of dendritic cell versus targeted-therapy in patients with metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsConcomitant trimodality therapy of re-irradiation, chemotherapy and regional hyperthermia for a pretreated inoperable sarcoma recurrence
/in Hyperthermia, International Publications, Soft Tissue SarcomaPET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue SarcomaCellular immunotherapy in ovarian cancer: Targeting the stem of recurrence
/in Dendritic Cells, International Publications, Ovarian CancerHyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling
/in Glioblastoma, Hyperthermia, International PublicationsDendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer
/in Dendritic Cells, International Publications, NSCLCHyperthermia restores apoptosis induced by death receptors through aggregation-induced c-FLIP cytosolic depletion
/in Hyperthermia, International PublicationsAntitumor Responses Stimulated by Dendritic Cells Are Improved by Triiodothyronine Binding to the Thyroid Hormone Receptor β
/in Dendritic Cells, International Publications, Thyroid Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer